Pacira BioSciences receives FDA 510k clearance for new iovera SmartTip

[ad_1] Ellington Credit Company declares $0.08 dividend [ad_2]

[ad_1] YinYang REGENXBIO (NASDAQ:RGNX) and Nippon Shinyaku have entered into a partnership for the development and commercialization of REGENXBIO’s gene therapies RGX-121 for the treatment of Hunter syndrome, or MPS II, and RGX-111 for Hurler syndrome, or MPS I. Under the deal, REGENXBIO ( [ad_2]

[ad_1] LD The Federal Trade Commission has referred a complaint against Snap Inc. (NYSE:SNAP) to the Department of Justice, according to a public statement made by the U.S. government agency Thursday. The complaint against the Snapchat parent is connected to the deployment [ad_2]

[ad_1] Paranovus Entertainment regains Nasdaq compliance [ad_2]